Arine Vlieger, MD, PhD
St. Antonius Hospital
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Huacheng Liu
Second Affiliated Hospital of Wenzhou Medical University
Shared therapeutic areas:
Ru-Lan Hsieh, MD
Shin Kong Wu Ho-Su Memorial Hospital
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Yanqing Li, PhD. MD.
Department of Gastroenterology, Qilu Hospital, Shandong University
Shared therapeutic areas:
Charles Conway, MD
Washington University School of Medicine
Shared therapeutic areas:
Nobuhito Sanada
Otsuka Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Imran Amjad, Phd
Riphah International University
Shared therapeutic areas:
Marie Carmen Valenza, phD
Universidad de Granada
Shared therapeutic areas:
Lei Li, M.D.
Peking Union Medical College Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study
The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.
All 2 trials loaded